Polidocanol for endovenous microfoam sclerosant therapy
- PMID: 19912070
- PMCID: PMC2787977
- DOI: 10.1517/13543780903376163
Polidocanol for endovenous microfoam sclerosant therapy
Abstract
Background: Polidocanol is a liquid surfactant having endothelial cell lytic properties. In the form of a controlled, dispensed microfoam it is administered endovenously as a sclerosing agent in the treatment of varicose veins.
Objective: This review summarizes efficacy of polidocanol endovenous microfoam sclerotherapy using a proprietary dispensing system to control foam characteristics and gas content for treating varicose veins.
Methods: We reviewed in vitro, Phase I, Phase II and limited Phase III data for polidocanol microfoam with a focus on controlled foam formulation in therapy.
Results/conclusions: Clinical trials of controlled dispensing of polidocanol microfoam provide evidence of effective treatment of chronic venous insufficiency with low toxicity, minimal risk and few complications.
Conflict of interest statement
The author has no conflict of interest to declare and no fee has been received for preparation of the manuscript.
Figures
Similar articles
-
The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.Phlebology. 2014 Oct;29(9):608-18. doi: 10.1177/0268355513497709. Epub 2013 Jul 17. Phlebology. 2014. PMID: 23864535 Clinical Trial.
-
Treatment of Truncal Incompetence and Varicose Veins with a Single Administration of a New Polidocanol Endovenous Microfoam Preparation Improves Symptoms and Appearance.Eur J Vasc Endovasc Surg. 2015 Dec;50(6):784-93. doi: 10.1016/j.ejvs.2015.06.111. Epub 2015 Sep 16. Eur J Vasc Endovasc Surg. 2015. PMID: 26384639 Clinical Trial.
-
Sclerotherapy: a study comparing polidocanol in foam and liquid form.Phlebology. 2010 Feb;25(1):44-9. doi: 10.1258/phleb.2009.008064. Phlebology. 2010. PMID: 20118346 Clinical Trial.
-
Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.Phlebology. 2018 Apr;33(3):150-162. doi: 10.1177/0268355516687864. Epub 2017 Feb 6. Phlebology. 2018. PMID: 28166694 Review.
-
Sclerotherapy and foam sclerotherapy for varicose veins.Phlebology. 2009 Dec;24(6):260-9. doi: 10.1258/phleb.2009.009050. Phlebology. 2009. PMID: 19952382 Review.
Cited by
-
Embolo/sclerotherapy for the treatment of hand arteriovenous malformations: a single-center retrospective cohort experience.Front Surg. 2023 Jun 16;10:1191876. doi: 10.3389/fsurg.2023.1191876. eCollection 2023. Front Surg. 2023. PMID: 37396293 Free PMC article.
-
Large Anorectal Venous Malformation Treated With Microfoam Therapy.ACG Case Rep J. 2023 Mar 31;10(3):e01015. doi: 10.14309/crj.0000000000001015. eCollection 2023 Mar. ACG Case Rep J. 2023. PMID: 37021280 Free PMC article.
-
Effective viral-mediated lung gene therapy: is airway surface preparation necessary?Gene Ther. 2023 Jun;30(6):469-477. doi: 10.1038/s41434-022-00332-7. Epub 2022 Mar 29. Gene Ther. 2023. PMID: 35351979 Free PMC article. Review.
-
A Novel Drug Self-Delivery System from Fatty Alcohol Esters of Tranexamic Acid for Venous Malformation Sclerotherapy.Pharmaceutics. 2022 Feb 1;14(2):343. doi: 10.3390/pharmaceutics14020343. Pharmaceutics. 2022. Retraction in: Pharmaceutics. 2024 Jan 30;16(2):199. doi: 10.3390/pharmaceutics16020199. PMID: 35214075 Free PMC article. Retracted.
-
The Efficacy and Health Economics of Different Treatments for Type 1 Cesarean Scar Pregnancy.Front Pharmacol. 2022 Jan 28;13:822319. doi: 10.3389/fphar.2022.822319. eCollection 2022. Front Pharmacol. 2022. PMID: 35153794 Free PMC article.
References
-
- Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005;15:175–84. - PubMed
-
- Kundu S, Lurie F, Millward SF, et al. Recommended reporting standards for endovenous ablation for the treatment of venous insufficiency: joint statement of The American Venous Forum and The Society of Interventional Radiology. J Vasc Surg. 2007;46:582–9. - PubMed
-
- Mozes G, Kalra M, Carmo M, et al. Extension of saphenous thrombus into the femoral vein: a potential complication of new endovenous ablation techniques. J Vasc Surg. 2005;41:130–5. - PubMed
-
- Wollmann JC. The history of sclerosing foams. Dermatol Surg. 2004;30:694–703. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources